7
First Capital Research Analyst: Atchuthan Srirangan Earnings Update SRI LANKA Page | 1 GLAS performs above expectations in 2QFY18: GLAS earnings jumped to LKR 49Mn in spite of the slow economic conditions prevailed in the country and higher than expected finance cost. Stronger than expected revenue growth has led FC Research upgrading its revenue forecasts by +4% (LKR 375Mn) for FY18E and +2% (LKR 180Mn) which resulted in a boost in the expected earnings as well. We expect a stable growth in revenue within coming quarters as well, as GLAS starts to fully utilize its newly expanded capacity. We have upgraded our GLAS earnings expectations for FY18E by +40Mn to LKR 517Mn and in FY19E by +65Mn to LKR 743Mn. However, despite of the upgrade our GLAS fair value is maintained at LKR 8.8 as the rise in PER valuation has been off-set by the dip in DCF valuation amidst higher than expected gearing structure of GLAS which has moved from 70:30 to 60:40 structure likely to be maintained. Our recommendation for the counter stands at STRONG BUY with stronger expected returns as price marginally dips amidst market volatility. Earnings Performance 2QFY18 earnings up by 134%YoY: GLAS 2QFY18 earnings saw an upward movement of 134%YoY to LKR 49Mn despite an acceleration in finance cost and taxation costs, while 2HFY18 earning grew by 110%YoY to LKR 154.6Mn opposed LKR 73.4Mn recorded in 2HFY17. NOV 2017 Current Price – LKR 6.00 Fair Value – LKR 8.80 2QFY18 Earnings 134%YoY PIRAMAL GLASS CEYLON PLC CSE: GLAS.N0000 Bloomberg: GLAS SL STRONG BUY “Stronger revenue upgrades earnings” Disclosure on Shareholding: First Capital Group and its affiliates does not hold shares of GLAS and will not trade in this share for the three trading days following the issue of this document. Price – Volume Chart ANALYST CERTIFICATIONS AND REQUIRED DISCLOSURES BEGIN ON PAGE 6 KEY DATA Share Price (LKR) Average Daily Volume (Shares) 316,661 Average Daily Turnover (LKR) 2,211,307 950 5,701 Price Performance (%) 1 mth 3 mths 12mths GLAS -4.8% -1.6% 11.1% ASPI -1.7% 1.0% 2.1% 56.5% 9.5% 2.9% 1.9% 1.7% CITI Bank New York S/A Norges Bank Accou CB NY S/A Salient International Dividend Si Union Assurance PLC/ Account No.05 Public Holdings 43.5% Issued Share Capital (Shares mn) Market Capitalisation (LKR mn) Major Shareholders as at 31st September 2017 Piramal Glass Limited Employees Provident Fund 6.00 52w High/Low (LKR) 6.40 / 5.20 - 1 2 3 4 5 6 7 8 9 10 5.2 5.4 5.6 5.8 6.0 6.2 6.4 6.6 6.8 Price LKR Volume - Mn Source: CSE P/E 31 March FY16 FY17 FY18E FY19E FY20E Revenue (LKR mn) 6,755 6,783 7,706 9,245 10,163 Net Profit (LKR Mn) 654 485 517 743 893 Net Profit (LKR Mn) 654 485 517 743 893 EPS (LKR) 0.69 0.51 0.54 0.78 0.94 YoY % Growth 49% -26% 6% 44% 20% Valuations PER (X) 8.7 11.7 11.0 7.7 6.4 PBV (X) 1.4 1.4 1.3 1.2 1.1 Dividend Yield (%) 5.8% 4.3% 4.6% 6.6% 8.0% NAVPS 4.3 4.4 4.7 5.1 5.5 DPS (LKR) 0.4 0.3 0.3 0.4 0.5 Payout Ratio 51% 51% 51% 51% 51% LKR (Mn) 2QFY18 2QFY17 YoY 2HFY18 2HFY17 YoY Revenue 1,679 1,445 16% 3,082 3,129 -1% Gross Profit 345 94 265% 696 401 74% EBIT 203 (33) 620% 418 119 250% Income tax expense (72) 12 619% (106) (20) 434% Profit for the year 49 (37) 134% 154 76 103% LKR (Mn) 3QFY17 4QFY17 1QFY18 2QFY18 QoQ Revenue 1,979 1,675 1,403 1,679 20% Gross Profit 533 438 351 345 -2% EBIT 332 331 215 203 -5% Income tax expense (56) (42) (34) (72) 113% Profit for the year 202 210 105 49 -53%

EPS (LKR) 0.69 0.51 0.54 0.78 0.94 ASPI -1.7% 1.0% 2.1% ... Sri Lanka PLC, Cargills (Ceylon) PLC, Carsons Cumberbatch, GlaxoSmithKline Pharmaceuticals, Coca-Cola is exported to countries

Embed Size (px)

Citation preview

Page 1: EPS (LKR) 0.69 0.51 0.54 0.78 0.94 ASPI -1.7% 1.0% 2.1% ... Sri Lanka PLC, Cargills (Ceylon) PLC, Carsons Cumberbatch, GlaxoSmithKline Pharmaceuticals, Coca-Cola is exported to countries

First Capital Research Analyst: Atchuthan Srirangan

Earnings Update

SRI LANKA

P a g e | 1

GLAS performs above expectations in 2QFY18: GLAS earnings jumped to LKR 49Mn in spite of the slow economic conditions prevailed in the country and higher than expected finance cost. Stronger than expected revenue growth has led FC Research upgrading its revenue forecasts by +4% (LKR 375Mn) for FY18E and +2% (LKR 180Mn) which resulted in a boost in the expected earnings as well. We expect a stable growth in revenue within coming quarters as well, as GLAS starts to fully utilize its newly expanded capacity. We have upgraded our GLAS earnings expectations for FY18E by +40Mn to LKR 517Mn and in FY19E by +65Mn to LKR 743Mn. However, despite of the upgrade our GLAS fair value is maintained at LKR 8.8 as the rise in PER valuation has been off-set by the dip in DCF valuation amidst higher than expected gearing structure of GLAS which has moved from 70:30 to 60:40 structure likely to be maintained. Our recommendation for the counter stands at STRONG BUY with stronger expected returns as price marginally dips amidst market volatility.

Earnings Performance 2QFY18 earnings up by 134%YoY: GLAS 2QFY18 earnings saw an upward movement of 134%YoY to LKR 49Mn despite an acceleration in finance cost and taxation costs, while 2HFY18 earning grew by 110%YoY to LKR 154.6Mn opposed LKR 73.4Mn recorded in 2HFY17.

NOV 2017 Current Price – LKR 6.00 Fair Value – LKR 8.80 2QFY18 Earnings 134%YoY

PIRAMAL GLASS CEYLON PLC CSE: GLAS.N0000 Bloomberg: GLAS SL STRONG BUY

“Stronger revenue upgrades earnings”

Disclosure on Shareholding: First Capital Group and its affiliates does not hold shares of GLAS and will not trade in this share for the three trading days following the issue of this document.

Price – Volume Chart

ANALYST CERTIFICATIONS AND REQUIRED DISCLOSURES BEGIN ON PAGE 6

KEY DATA

Share Price (LKR)

Average Daily Volume (Shares) 316,661

Average Daily Turnover (LKR) 2,211,307

950

5,701

Price Performance (%) 1 mth 3 mths 12mths

GLAS -4.8% -1.6% 11.1%

ASPI -1.7% 1.0% 2.1%

56.5%

9.5%

2.9%

1.9%

1.7%

CITI Bank New York S/A Norges Bank Account 2

CB NY S/A Salient International Dividend Signal Fund

Union Assurance PLC/ Account No.05

Public Holdings 43.5%

Issued Share Capital (Shares mn)

Market Capitalisation (LKR mn)

Major Shareholders as at 31st September 2017

Piramal Glass Limited

Employees Provident Fund

6.00

52w High/Low (LKR) 6.40 / 5.20

-

1

2

3

4

5

6

7

8

9

10

5.2

5.4

5.6

5.8

6.0

6.2

6.4

6.6

6.8

Pri

ce L

KR V

olu

me

-M

n

Source: CSE

P/E 31 March FY16 FY17 FY18E FY19E FY20E

Revenue (LKR mn) 6,755 6,783 7,706 9,245 10,163

Net Profit (LKR Mn) 654 485 517 743 893

Net Profit (LKR Mn) 654 485 517 743 893

EPS (LKR) 0.69 0.51 0.54 0.78 0.94

YoY % Growth 49% -26% 6% 44% 20%

Valuations

PER (X) 8.7 11.7 11.0 7.7 6.4

PBV (X) 1.4 1.4 1.3 1.2 1.1

Dividend Yield (%) 5.8% 4.3% 4.6% 6.6% 8.0%

NAVPS 4.3 4.4 4.7 5.1 5.5

DPS (LKR) 0.4 0.3 0.3 0.4 0.5

Payout Ratio 51% 51% 51% 51% 51%

LKR (Mn) 2QFY18 2QFY17 YoY 2HFY18 2HFY17 YoY

Revenue 1,679 1,445 16% 3,082 3,129 -1%

Gross Profit 345 94 265% 696 401 74%

EBIT 203 (33) 620% 418 119 250%

Income tax expense (72) 12 619% (106) (20) 434%

Profit for the year 49 (37) 134% 154 76 103%

LKR (Mn) 3QFY17 4QFY17 1QFY18 2QFY18 QoQ

Revenue 1,979 1,675 1,403 1,679 20%

Gross Profit 533 438 351 345 -2%

EBIT 332 331 215 203 -5%

Income tax expense (56) (42) (34) (72) 113%

Profit for the year 202 210 105 49 -53%

Page 2: EPS (LKR) 0.69 0.51 0.54 0.78 0.94 ASPI -1.7% 1.0% 2.1% ... Sri Lanka PLC, Cargills (Ceylon) PLC, Carsons Cumberbatch, GlaxoSmithKline Pharmaceuticals, Coca-Cola is exported to countries

First Capital Research Analyst: Atchuthan Srirangan

Earnings Update

SRI LANKA

P a g e | 2

GP Margin increased 21%: GLAS showed improvement in GP margin which rose to 21% during 2QFY18 as compared with 2QFY17. Improvement in GP Margin was possible due to the reduction of trading sales. Well stabilized new in-house capacity has managed to cater to the domestic and export market replacing the imported bottles. Last year due to capacity constraints a considerable portion of the domestic sale was done through imports. Revenue growth supported by export sales: Topline improved by 16%YoY to LKR 1.7Bn in 2QFY18 compared to the 2QFY17 LKR 1.4Bn. The Domestic sale 2QFY18 stood at LKR 1.1Bn as against LKR 1.2Bn in 2QFY17, reflecting a de-growth of 11%. A dip in the overall domestic market was experienced which impacted the sales mainly in the food & beverage segments. GLAS made special efforts to expand in the export market to offset the domestic setback. Therefore the high growth seen in the export market is an outcome of the initiatives proactively converted to sales in the newer markets. GLAS has demonstrated its capability by achieving export sales for 2QFY18 of LKR 579Mn as against the LKR 206Mn received in 2QFY17 which depicted a growth of 181%. EBIT margins improved YoY & dropped QoQ: EBIT margins for 2QFY18 registered 12.1% in 2QFY18 illustrating a significant improvement compared to -2.3% in 2QFY17 and 8.9% in 1QFY17. Higher finance cost: GLAS incur high finance expenses 1HFY18 579%YoY increased to LKR 158Mn arising from the debt absorbed for the furnace refurbishment. Total borrowing increased 25%YoY in 2QFY18 to LKR 3.5Bn compare with 2QFY17.

Investment case

GLAS fair value to be at LKR 8.80: FC Research expect GLAS’s earnings to record at c.LKR 827Mn for FY19E, growing by 54%YoY. We expect a fair value of LKR 8.80 [LKR 10.30 DCF based and LKR 7.40 PER based] providing an annualized return of c.+34% for FY19E. (Total return of c.+47% includes a dividend yield of c.4%) at current market price of LKR 6.0.

Significant capacity expansion and strong customer relationships, leading to attractive business mode: With the relining of the furnace and infrastructure upgrade in line with the latest international standards, the GLAS is fully geared to attain greater heights in the local market as well as in the international market. This additional tonnage would be channeled first towards satisfying the local market demand for virgin coconut oil exports, water bottles in various sizes, incremental demand for aerated bottles due to shift in consumer preference over PET/ Plastics, returnable bottles in liquor segments and then towards specialty segment in the international market. The upgraded facility will also enable GLAS to deliver more innovative designs in different sizes and colors. Strong market share in each of its business segments: GLAS also operates South East Asia’s only fore hearth color bottles production facility. Raw materials include Soda Ash (which are being imported from China and Turkey), Dolomite and Silica (which are being obtained locally (Naththandiya). Main local customers include Distilleries Co. of Sri Lanka PLC, Cargills (Ceylon) PLC, Carsons Cumberbatch, GlaxoSmithKline Pharmaceuticals, Coca-Cola Beverages Sri Lanka and Unilever Sri Lanka Ltd. Around 25% is exported to countries like Australia, New- Zealand, Kenya, UAE, Philippines, Mauritius, Maldives.

Investment risks

Commodity Price Risk: The Entity is affected by the availability & price of certain commodities. The main impact for GLAS is through energy & Imported Raw Material. The imported Raw material price risk is mitigated through long term agreements & central purchasing done by GLAS Procurement division. The energy cost consists of LPG, Furnace oil & Electricity. In managing the commodity price risk part of the cost increases are passed on to the customer through the annual price increases. Interest Rate Risk: Interest rate risk is the risk that the GLAS’s financial position will be adversely affected by movements in floating interest. All of the GLAS’s interests are linked to variable rates. The GLAS exposure to interest rate risk is minimized by maintaining an appropriate mix between Rupee borrowings & Dollar borrowing. The fluctuating rate variance of Rupee borrowing is minimized by the LIBOR linked Dollar borrowing whilst the Exchange exposure of the Dollar loan is minimized by the Rupee loan. Exchange Rate Risk: Exchange risk arises out of the commercial transactions that the entity enters into outside Sri Lanka. The major part of the foreign transactions is dealt with US Dollars. GLAS has a natural hedging by way of its operational transactions as the inflow of foreign currency through export sale off sets the import cost and the US dollar loan premium and interest.

Page 3: EPS (LKR) 0.69 0.51 0.54 0.78 0.94 ASPI -1.7% 1.0% 2.1% ... Sri Lanka PLC, Cargills (Ceylon) PLC, Carsons Cumberbatch, GlaxoSmithKline Pharmaceuticals, Coca-Cola is exported to countries

First Capital Research Analyst: Atchuthan Srirangan

Earnings Update

SRI LANKA

P a g e | 3

WACC

Ke 17%

Kd 10%

D/E Assumption 40 / 60

Terminal Growth (%) 3%

WACC 14%

PER based Valuation

FY19E Earnings (LKR 'Mn) 743

No. of Shares ('Mn) 950

FY19E EPS 0.78

Expected PER 10x

Price at 10.0x FY19E Earnings 7.4

Valuations FY19

NPV 11,674

Debt (-) -2,632

Cash (+) 721

Total Value of Equity 9,764

No. of Shares 950

Value of Equty per Share 10.3

Valuation Summary DCF Based Valuation PER Valuation

Recommendation criteria

Categorization Company Category Strong Buy Buy Hold Sell

Grade A S&P SL20 CompaniesT.Bill + 10%

& Above

T.Bill + 5% &

Above

T.Bill + 1% &

Above

Below T.Bill

+ 1%

Grade B Rest of the CompaniesT.Bill + 13%

& Above

T.Bill + 8% &

Above

T.Bill + 3% &

Above

Below T.Bill

+ 3%

Grade CCompanies less than

LKR 1Bn Market Cap

T.Bill + 16%

& Above

T.Bill + 11%

& Above

T.Bill + 6% &

Above

Below T.Bill

+ 6%

Note: 1 year T-bill rate as of 15 Nov 2017: 9.46%

Expected GLAS Price FY19E

DCF Valuation based target price 10.3

PER based target price 7.4

Average Target Price 8.8

GLAS

Return FY19E

Target Price 8.80

Current Price 6.00

Capital Gain (LKR) 2.80

Dividend(LKR) 0.25

Capital Gain % 47%

Dividend Yield % 4%

Total Return % 51%

Annaulised Return % 34%

COE (K e)

Rf 9%

Rm 18%

1.10

Ke=Rf+ (Rm-Rf) 18%

-

2.0

4.0

6.0

8.0

10.0

12.0

14.0

4.00 6.00 8.00 10.00 12.00 Price

Source: CSE and Research Estimates

Page 4: EPS (LKR) 0.69 0.51 0.54 0.78 0.94 ASPI -1.7% 1.0% 2.1% ... Sri Lanka PLC, Cargills (Ceylon) PLC, Carsons Cumberbatch, GlaxoSmithKline Pharmaceuticals, Coca-Cola is exported to countries

First Capital Research Analyst: Atchuthan Srirangan

Earnings Update

SRI LANKA

P a g e | 4

Profit & Loss Statement

P/E 31 March FY16 FY17 FY18E FY19E FY20E

Revenue 6,755 6,783 7,706 9,245 10,163

Cost of Sales (5,258) (5,412) (6,142) (7,265) (7,963)

Gross Profit 1,497 1,371 1,563 1,980 2,200

Other Operating Income 5 29 33 40 44

Profit on Disposal of Investment Property - - - - -

Distribution Costs (218) (212) (238) (276) (309)

Administrative Expenses (405) (409) (434) (499) (554)

PBIT 879 779 925 1,245 1,381

Finance Cost (74) (176) (207) (214) (141)

Profit/(Loss) Before Tax 805 603 717 1,031 1,240

Taxation (150) (117) (201) (289) (347)

Net Profit 654 485 517 743 893

EPS 0.69 0.51 0.54 0.78 0.94

Annex I – Income Statement Annex II – Balance Sheet

Source: Company Annual Reports and FC Research Estimates

Source: Company Annual Reports and FC Research Estimates

Balance Sheet

P/E 31 March FY16 FY17 FY18E FY19E FY20E

Assets

Non - Current Assets

Property, Plant and Equipment 3,692 6,178 5,789 5,573 5,326

Leasehold Land 25 24 22 21 20

3,725 6,210 5,819 5,603 5,354

Current Assets

Inventories 1,444 1,446 1,695 1,942 2,134

Trade and Other Receivables 1,319 1,098 1,580 1,803 1,982

Other 6 39 39 39 39

Cash and Bank Balances 161 274 207 381 18

2,931 2,856 3,521 4,164 4,173

Total Assets 6,656 9,066 9,340 9,767 9,526

Equity and Liabilties

Capital and Reserves

Stated Capital 1,526 1,526 1,526 1,526 1,526

Reserves 131 129 129 129 129

Retained Earnings 2,410 2,555 2,809 3,175 3,614

4,067 4,211 4,465 4,830 5,270

Non - Current Liabilities

Interest Bearing Loans and Borrowings 472 2,719 1,575 1,448 970

Deferred Tax Liabilities 149 277 277 277 277

Retirement Benefit Obligations 121 142 154 167 181

742 3,139 2,007 1,892 1,428

Current Liabilities

Trade and Other Payables 1,355 923 1,536 1,816 1,991

Dividends Payable 59 44 44 44 44

Income Tax Payable 36 - - - -

Interest Bearing Loans and Borrowings 396 749 1,289 1,184 794

1,847 1,716 2,868 3,044 2,829

Total Equity & Liabilties 6,656 9,066 9,340 9,767 9,526

Page 5: EPS (LKR) 0.69 0.51 0.54 0.78 0.94 ASPI -1.7% 1.0% 2.1% ... Sri Lanka PLC, Cargills (Ceylon) PLC, Carsons Cumberbatch, GlaxoSmithKline Pharmaceuticals, Coca-Cola is exported to countries

First Capital Research Analyst: Atchuthan Srirangan

Earnings Update

SRI LANKA

P a g e | 5

Annex III – Cash Flow Statement

Source: Company Annual Reports and FC Research Estimates

Cashflow Statement

P/E 31 March FY16 FY17 FY18E FY19E FY20E

Net Profit Before Tax 805 603 717 1,031 1,240

Adjustments 573 736 921 956 917

Changes in Working Capital 203 (324) (118) (189) (197)

Inerest paid (74) (176) (207) (214) (141)

Defined Benefit Obligations paid (19) (12) (12) (13) (14)

Tax Paid - (45) (201) (289) (347)

Net cashflow from operating activities 1,488 781 1,101 1,283 1,458

Investing Activities

Fixed Assets (392) (2,962) (300) (500) (500)

Net cashflow from investing activities (390) (2,934) (300) (500) (500)

Financing Activities

Net Borrowings (850) 2,598 (604) (232) (868)

Dividends (215) (325) (262) (377) (454)

Net Cashflow from financing activities (1,065) 2,273 (867) (610) (1,321)

Net cash and cash equivalents 33 120 (66) 173 (363)

At start of the year 107 140 260 193 367

At the End of period 140 260 193 367 4

Cash of Balance Sheet 140 260 207 381 18

Bank Overdraft - - (14) (14) (14)

Net cash from Cashflow 140 260 193 367 4

Page 6: EPS (LKR) 0.69 0.51 0.54 0.78 0.94 ASPI -1.7% 1.0% 2.1% ... Sri Lanka PLC, Cargills (Ceylon) PLC, Carsons Cumberbatch, GlaxoSmithKline Pharmaceuticals, Coca-Cola is exported to countries

First Capital Research Analyst: Atchuthan Srirangan

Earnings Update

SRI LANKA

P a g e | 6

Research Disclosure

NOTICE TO US INVESTORS

This report was prepared, approved, published and distributed by First Capital Equities (Pvt) Ltd, company located outside of the United States (a “non-US Group Company”). This report is distributed in the U.S. by LXM LLP USA, a U.S. registered broker dealer, on behalf of First Capital Equities (Pvt) Ltd only to major U.S. institutional investors (as defined in Rule 15a-6 under the U.S. Securities Exchange Act of 1934 (the “Exchange Act”)) pursuant to the exemption in Rule 15a-6 and any transaction effected by a U.S. customer in the securities described in this report must be effected through LXM LLP USA.

Neither the report nor any analyst who prepared or approved the report is subject to U.S. legal requirements or the Financial Industry Regulatory Authority, Inc. (“FINRA”) or other regulatory requirements pertaining to research reports or research analysts. No non-US Group Company is registered as a broker-dealer under the Exchange Act or is a member of the Financial Industry Regulatory Authority, Inc. or any other U.S. self-regulatory organization. Analyst Certification. Each of the analysts identified in this report certifies, with respect to the companies or securities that the individual analyses, that (1) the views expressed in this report reflect his or her personal views about all of the subject companies and securities and (2) no part of his or her compensation was, is or will be directly or indirectly dependent on the specific recommendations or views expressed in this report. Please bear in mind that (i) First Capital Equities (Pvt) Ltd is the employer of the research analyst(s) responsible for the content of this report and (ii) research analysts preparing this report are resident outside the United States and are not associated persons of any US regulated broker-dealer and that therefore the analyst(s) is/are not subject to supervision by a US broker-dealer, and are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with US rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. Important US Regulatory Disclosures on Subject Companies. This material was produced by Analysis First Capital Equities (Pvt) Ltd solely for information purposes and for the use of the recipient. It is not to be reproduced under any circumstances and is not to be copied or made available to any person other than the recipient. It is distributed in the United States of America by LXM LLP USA and elsewhere in the world by First Capital Equities (Pvt) Ltd or an authorized affiliate of First Capital Equities (Pvt) Ltd. This document does not constitute an offer of, or an invitation by or on behalf of First Capital Equities (Pvt) Ltd or its affiliates or any other company to any person, to buy or sell any security. The information contained herein has been obtained from published information and other sources, which First Capital Equities (Pvt) Ltd or its Affiliates consider to be reliable. None of First Capital Equities (Pvt) Ltd accepts any liability or responsibility whatsoever for the accuracy or completeness of any such information. All estimates, expressions of opinion and other subjective judgments contained herein are made as of the date of this document. Emerging securities markets may be subject to risks significantly higher than more established markets. In particular, the political and economic environment, company practices and market prices and volumes may be subject to significant variations. The ability to assess such risks may also be limited due to significantly lower information quantity and quality. By accepting this document, you agree to be bound by all the foregoing provisions. LXM LLP USA assumes responsibility for the research reports content in regards to research distributed in the U.S. LXM LLP USA or its affiliates has not managed or co-managed a public offering of securities for the subject company in the past 12 months, has not received compensation for investment banking services from the subject company in the past 12 months, does not expect to receive and does not intend to seek compensation for investment banking services from the subject company in the next 3 months. LXM LLP USA has never owned any class of equity securities of the subject company. There are not any other actual, material conflicts of interest of LXM LLP USA at the time of the publication of this research report. As of the publication of this report LXM LLP USA, does not make a market in the subject securities.

Page 7: EPS (LKR) 0.69 0.51 0.54 0.78 0.94 ASPI -1.7% 1.0% 2.1% ... Sri Lanka PLC, Cargills (Ceylon) PLC, Carsons Cumberbatch, GlaxoSmithKline Pharmaceuticals, Coca-Cola is exported to countries

No. 02, Deal Place, General: +94 11 2639 898

Colombo 03. Fax: +94 11 5736 264

Dimantha Mathew +94 11 2639 853 Amanda Lokugamage +94 11 2639 868 Kandy Kurunegala

Atchuthan Srirangan +94 11 2639 863 Michelle Weerasinghe +94 11 2639 866 CSE - Kandy Branch, CSE - Kurunegala Branch,

Hansinee Beddage +94 11 2639 864 "Ceybank House", 1st Floor, Union Assurance Building,

No: 88, Sri Dalada Veediya, No 06, Rajapihilla Mawatha,

Kandy 20000. Kurunegala 60000.

Roshana Samarakoon +94 77 3363 820 Anjelo Simmons +94 77 3031 636 Manager: Salinda Samarakoon Manager: Menaka Wavegedara

Anushka Dissanayake +94 77 2220 021 Arun Kandasamy +94 75 4861 506 Tel: +94 81 2236 010 Tel: +94 37 2222 930

Anushi Ranawaka +94 77 3876 819

Matara Negombo

2nd Floor, E.H. Cooray Building No: 163B,

No: 24, 1/3, Colombo Road,

Sewwandi Kathriarachchi +94 77 3461 734 Naveen Samarasekera +94 77 0073 684 Anagarika Dharmapala Mawatha, Negombo 11500

Nethalie De Mel +94 11 2639 854 Kemith De Zoysa +94 77 2390 691 Matara 81000. Negombo 11500.

Manager: Rohana Jayakody Manager: Buddhika Edirisinghe

CEO Jaliya Wijeratne +94 70 2910 042 Negombo Tel: +94 41 2222 988 Tel: +94 31 4937 072

Priyanka Anuruddha +94 70 2910 035

Colombo Priyantha Wijesiri +94 70 2910 036

Damian Le Grand +94 70 2910 032

Nishantha Mudalige +94 70 2910 041

Isuru Jayawardana +94 70 2910 034

Ifadh Marikar +94 70 2910 033

Thushara Pathiraja +94 70 2910 037

Anushka Buddhika +94 70 2910 030

Gamini Hettiarachchi +94 70 2910 039

Kosala Liyanagedara +94 77 7230 788 Poorni Fernando +94 77 2440 531

DisclamerThis Review is prepared and issued by First Capital Equities (Pvt) Ltd. based on information in the public domain, internally developed and other sources, believed to be correct. Although all reasonable care has been taken to ensure the contents of the Review are accurate, First Capital Equities (Pvt) Ltd and/or its Directors,

employees, are not responsible for the correctness, usefulness, reliability of same.  First Capital Equities (Pvt) Ltd may act as a Broker in the investments which are the subject of this document or related investments  and may have acted on or used the information contained in this document, or the research or analysis on

which it is based, before its publication.  First Capital Equities (Pvt) Ltd and/or its principal, their respective Directors, or Employees may also have a position or be otherwise interested in the investments referred to in this document. This is not an offer to sell or buy the investments referred to in this document. This Review

may contain data which are inaccurate and unreliable.  You hereby waive irrevocably any rights or remedies in law or equity you have or may have against First Capital Equities (Pvt) Ltd with respect  to the Review  and agree to indemnify and hold First Capital Equities (Pvt) Ltd and/or its principal, their respective directors

and employees harmless to the fullest extent allowed by law regarding all matters related to your use of this Review. No part of this document may be reproduced, distributed or published in whole or in part by any means to any other person for any purpose without prior permission.

About us

UNIT TRUST SALES

This report providing a snapshot of fixed income, equity and unit trust is composed and

circulated by First Capital Holdings PLC an investment bank in Sri Lanka. The company

operates in the capital market of Sri Lanka with operations in government securities - treasury

bills and bonds, stock brokering and share market investments, asset management, private

wealth management, retirement planning, personal financial planning, unit trust, margin

trading, capital market research, trustee services, corporate finance advisory services

including corporate debt structuring (debentures, trust certificates, commercial papers),

valuations, restructuring, mergers and acquisitions, initial public offerings (IPOs) and project

advisory. The First Capital Group consists of First Capital Treasuries PLC, First Capital Limited,

First Capital Markets Limited, First Capital Asset Management Limited and First Capital

Equities (Private) Limited covering Colombo, Negombo, Matara, Kandy and Kurunegala.

First Capital Holdings PLC

RESEARCH

GOVERNMENT SECURITIES SALES

CORPORATE DEBT SALES

EQUITY SALES

BRANCHES

FIRST CAPITAL RESEARCH